Prof. Raquel Lieberman

MoSE G011
Thursday, August 24, 2017 - 4:00pm to 5:00pm

Molecular characterization of myocilin: pathway to new treatments for glaucoma

The Lieberman lab uses biophysical, structural, and chemical biology approaches to characterize proteins involved in conformational disorders and ameliorate the misfolding phenotype. A major research effort in the lab has been investigations of the myocilin, which is implicated in familial cases of the prevalent ocular disorder glaucoma.  I will present our efforts toward a detailed molecular understanding of myocilin structure, function, and disease pathogenesis, including striking similarities with amyloid diseases, as well as new directions for glaucoma therapeutics.

Contact Information: 

Hosted by M. G. Finn

Map of Georgia Tech

School of Chemistry & Biochemistry

901 Atlantic Drive Atlanta, GA 30332-0400

(404) 894-4002 (phone) | (404) 894-7452 (fax)